Alfred Lochner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alfred Lochner has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christian Degen
Institute of Nutrition, Dept. of Nutritional Physiology, Friedrich Schiller University, Dornburger Str. 24, D-07743 Jena, Germany
1 shared publication - Gerhard Jahreis
Department of Nutritional Physiology, Institute of Nutrition, Friedrich Schiller University Jena, Dornburger Str. 24, Jena, Germany
1 shared publication - Katrin Kuhnt
Department of Nutritional Physiology, Institute of Nutrition, Friedrich Schiller University Jena, Dornburger Str. 24, Jena, Germany
1 shared publication - Sven Dänicke
Friedrich- Loeffler- Institut, Federal Research Institute for Animal Health, Institute of Animal Nutrition (ITE), Braunschweig, Germany
1 shared publication - Sylvia Keller
Friedrich Schiller University of Jena, Department of Nutritional Physiology, Dornburger Straße 24, D-07743 Jena, Germany
1 shared publication
Latest Publications
- Open Access
- 4 August 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 131
Influence of in vitro supplementation with lipids from conventional and Alpine milk on fatty acid distribution and cell growth of HT-29 cells
Background: To date, the influence of milk and dairy products on carcinogenesis remains controversial. However, lipids of ruminant origin such as conjugated linoleic acids (CLA) are known to exhibit beneficial effectsin vitroandin vivo. The aim of the present study was to determine the influence of milk lipids of different origin and varying quality presenting as free fatty acid (FFA) solutions on cellular fatty acid distribution, cellular viability, and growth of human colon adenocarcinoma cells (HT-29).Methods: FAME of conventional and Alpine milk lipids (MLcon, MLalp) and cells treated with FFA derivatives of milk lipids were analyzed by means of GC-FID and Ag+-HPLC. Cellular viability and growth of the cells were determined by means of CellTiter-Blue®-assay and DAPI-assay (4',6-diamidino-2-phenylindole dihydrochloride), respectively.Results: Supplementation with milk lipids significantly decreased viability and growth of HT-29 cells in a dose- and time-dependent manner. MLalpshowed a lower SFA/MUFA ratio, a 8 fold increased CLA content, and different CLA profile compared to MLconbut did not demonstrate additional growth-inhibitory effects. In addition, total concentration and fatty acid distribution of cellular lipids were altered. In particular, treatment of the cells yielded highest amounts of two types of milk specific major fatty acids (μg FA/mg cellular protein) after 8 h of incubation compared to 24 h; 200 μM of MLcon(C16:0, 206 ± 43), 200 μM of MLalp(C18:1c9, (223 ± 19). Vaccenic acid (C18:1t11) contained in milk lipids was converted toc9,t11-CLA in HT-29 cells. Notably, the ratio oft11,c13-CLA/t7,c9-CLA, a criterion for pasture feeding of the cows, was significantly changed after incubation for 8 h with lipids from MLalp(3.6 - 4.8), compared to lipids from MLcon(0.3 - 0.6).Conclusions: Natural lipids from conventional and Alpine milk showed similar growth inhibitory effects. However, different changes in cellular lipid composition suggested a milk lipid-depending influence on cell sensitivity. It is expected that similar changes may also be evident in other cell lines. To our knowledge, this is the first study showing a varied impact of complex milk lipids on fatty acid distribution in a colon cancer cell line.
- 4 August 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 131
Open AccessInfluence of in vitro supplementation with lipids from conventional and Alpine milk on fatty acid distribution and cell growth of HT-29 cells
Background: To date, the influence of milk and dairy products on carcinogenesis remains controversial. However, lipids of ruminant origin such as conjugated linoleic acids (CLA) are known to exhibit beneficial effectsin vitroandin vivo. The aim of the present study was to determine the influence of milk lipids of different origin and varying quality presenting as free fatty acid (FFA) solutions on cellular fatty acid distribution, cellular viability, and growth of human colon adenocarcinoma cells (HT-29).Methods: FAME of conventional and Alpine milk lipids (MLcon, MLalp) and cells treated with FFA derivatives of milk lipids were analyzed by means of GC-FID and Ag+-HPLC. Cellular viability and growth of the cells were determined by means of CellTiter-Blue®-assay and DAPI-assay (4',6-diamidino-2-phenylindole dihydrochloride), respectively.Results: Supplementation with milk lipids significantly decreased viability and growth of HT-29 cells in a dose- and time-dependent manner. MLalpshowed a lower SFA/MUFA ratio, a 8 fold increased CLA content, and different CLA profile compared to MLconbut did not demonstrate additional growth-inhibitory effects. In addition, total concentration and fatty acid distribution of cellular lipids were altered. In particular, treatment of the cells yielded highest amounts of two types of milk specific major fatty acids (μg FA/mg cellular protein) after 8 h of incubation compared to 24 h; 200 μM of MLcon(C16:0, 206 ± 43), 200 μM of MLalp(C18:1c9, (223 ± 19). Vaccenic acid (C18:1t11) contained in milk lipids was converted toc9,t11-CLA in HT-29 cells. Notably, the ratio oft11,c13-CLA/t7,c9-CLA, a criterion for pasture feeding of the cows, was significantly changed after incubation for 8 h with lipids from MLalp(3.6 - 4.8), compared to lipids from MLcon(0.3 - 0.6).Conclusions: Natural lipids from conventional and Alpine milk showed similar growth inhibitory effects. However, different changes in cellular lipid composition suggested a milk lipid-depending influence on cell sensitivity. It is expected that similar changes may also be evident in other cell lines. To our knowledge, this is the first study showing a varied impact of complex milk lipids on fatty acid distribution in a colon cancer cell line.